Home > Insider Trading > Filing (0001209191-13-053042)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571865	W. Timothy Trost	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713	Svp, Cfo & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-11-15	3,409	$0.00	3,409	No	4	M	Direct
Common Stock	Disposition	2013-11-15	3,409	$15.63	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common	Restricted Stock Unit	Disposition	2013-11-15	3,409	$0.00	3,409	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-11-15		No	4	M	Direct

Footnotes

Acquisition resulted from the settlement of restricted stock units for common stock.
The sales reported in the Form 4 were effected pursuant to a Rule 10B5-1 Plan adopted by the reporting person on September 5, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.21 to $16.05, inclusive. The reporting person undertakes to provide to CMRX, any security holder of CMRX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Not applicable.